Structural constraints on human immunodeficiency virus type 1 Nef function

Virology

Volumn 368, Issue 1, 2007, Pages 7-16

  Raney, Alexa ^a   Shaw, Alice Y ^a   Foster, John L ^a   Garcia, J Victor ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD4 down modulation; GFP; HIV 1; MHC I down modulation; Nef; PAK 2 activation; Peptide tags; Structure function

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; P21 ACTIVATED KINASE 2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

ANTIGENS, CD4; CELL LINE; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN KINASE C; PROTEIN STRUCTURE, SECONDARY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35349019766     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.02.036     Document Type: Article

References (50)

1. Aiken C., and Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69 8 (1995) 5048-5056
2. Akari H., Arold S., Fukumori T., Okazaki T., Strebel K., and Adachi A. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74 6 (2000) 2907-2912
3. Arold S.T., and Baur A.S. Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem. Sci. 26 6 (2001) 356-363
4. Arold S., Franken P., Strub M.P., Hoh F., Benichou S., Benarous R., and Dumas C. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5 10 (1997) 1361-1372
5. Arold S., Hoh F., Domergue S., Birck C., Delsuc M.A., Jullien M., and Dumas C. Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein. Protein Sci. 9 6 (2000) 1137-1148
6. Arora V.K., Molina R.P., Foster J.L., Blakemore J.L., Chernoff J., Fredericksen B.L., and Garcia J.V. Lentivirus Nef specifically activates Pak2. J. Virol. 74 23 (2000) 11081-11087
7. Benichou S., Bomsel M., Bodeus M., Durand H., Doute M., Letourneur F., Camonis J., and Benarous R. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269 48 (1994) 30073-30076
8. Benson R.E., Sanfridson A., Ottinger J.S., Doyle C., and Cullen B.R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177 6 (1993) 1561-1566
9. Bentham M., Mazaleyrat S., and Harris M. The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation. J. Gen. Virol. 84 Pt. 10 (2003) 2705-2713
10. Blagoveshchenskaya A.D., Thomas L., Feliciangeli S.F., Hung C.H., and Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111 6 (2002) 853-866
11. Bresnahan P.A., Yonemoto W., and Greene W.C. Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4. J. Immunol. 163 6 (1999) 2977-2981
12. Briggs S.D., Scholtz B., Jacque J.M., Swingler S., Stevenson M., and Smithgall T.E. HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J. Biol. Chem. 276 27 (2001) 25605-25611
13. Brown A., Wang X., Sawai E., and Cheng-Mayer C. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J. Virol. 73 12 (1999) 9899-9907
14. Carl S., Greenough T.C., Krumbiegel M., Greenberg M., Skowronski J., Sullivan J.L., and Kirchhoff F. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J. Virol. 75 8 (2001) 3657-3665
15. Chowers M.Y., Spina C.A., Kwoh T.J., Fitch N.J., Richman D.D., and Guatelli J.C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68 5 (1994) 2906-2914
16. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., and Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 6665 (1998) 397-401
17. Craig H.M., Pandori M.W., and Guatelli J.C. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 95 19 (1998) 11229-11234
18. Craig H.M., Reddy T.R., Riggs N.L., Dao P.P., and Guatelli J.C. Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 271 1 (2000) 9-17
19. Fenard D., Yonemoto W., de Noronha C., Cavrois M., Williams S.A., and Greene W.C. Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J. Immunol. 175 9 (2005) 6050-6057
20. Foster J.L., Molina R.P., Luo T., Arora V.K., Huang Y., Ho D.D., and Garcia J.V. Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates. J. Virol. 75 4 (2001) 1672-1680
21. Garcia J.V., and Foster J.L. Structural and functional correlates between HIV-1 and SIV Nef isolates. Virology 226 2 (1996) 161-166
22. Garcia J.V., and Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350 6318 (1991) 508-511
23. Geyer M., Munte C.E., Schorr J., Kellner R., and Kalbitzer H.R. Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. J. Mol. Biol. 289 1 (1999) 123-138
24. Geyer M., Fackler O.T., and Peterlin B.M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2 7 (2001) 580-585
25. Geyer M., Yu H., Mandic R., Linnemann T., Zheng Y.H., Fackler O.T., and Peterlin B.M. Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J. Biol. Chem. 277 32 (2002) 28521-28529
26. Greenberg M.E., Bronson S., Lock M., Neumann M., Pavlakis G.N., and Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16 23 (1997) 6964-6976
27. Greenberg M., DeTulleo L., Rapoport I., Skowronski J., and Kirchhausen T. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr. Biol. 8 22 (1998) 1239-1242
28. Greenberg M.E., Iafrate A.J., and Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17 10 (1998) 2777-2789
29. Guy B., Kieny M.P., Riviere Y., Le Peuch C., Dott K., Girard M., Montagnier L., and Lecocq J.P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330 6145 (1987) 266-269
30. Hochrein J.M., Wales T.E., Lerner E.C., Schiavone A.P., Smithgall T.E., and Engen J.R. Conformational features of the full-length HIV and SIV Nef proteins determined by mass spectrometry. Biochemistry 45 25 (2006) 7733-7739
31. Janardhan A., Swigut T., Hill B., Myers M.P., and Skowronski J. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2 1 (2004) E6
32. Janvier K., Craig H., Le Gall S., Benarous R., Guatelli J., Schwartz O., and Benichou S. Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. J. Virol. 75 8 (2001) 3971-3976
33. Kestler III H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 4 (1991) 651-662
34. Lama J., Mangasarian A., and Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9 12 (1999) 622-631
35. Lu X., Yu H., Liu S.H., Brodsky F.M., and Peterlin B.M. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8 5 (1998) 647-656
36. Luo T., and Garcia J.V. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70 9 (1996) 6493-6496
37. Mangasarian A., Foti M., Aiken C., Chin D., Carpentier J.L., and Trono D. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6 1 (1997) 67-77
38. Mangasarian A., Piguet V., Wang J.K., Chen Y.L., and Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 3 (1999) 1964-1973
39. O'Neill E., Kuo L.S., Krisko J.F., Tomchick D.R., Garcia J.V., and Foster J.L. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J. Virol. 80 3 (2006) 1311-1320
40. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G., and Trono D. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2 3 (2000) 163-167
41. Renkema G.H., Manninen A., and Saksela K. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J. Virol. 75 5 (2001) 2154-2160
42. Roeth J.F., and Collins K.L. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70 2 (2006) 548-563
43. Ross T.M., Oran A.E., and Cullen B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9 12 (1999) 613-621
44. Sawai E.T., Baur A., Struble H., Peterlin B.M., Levy J.A., and Cheng-Mayer C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91 4 (1994) 1539-1543
45. Schwartz O., Marechal V., Le Gall S., Lemonnier F., and Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2 3 (1996) 338-342
46. Swigut T., Alexander L., Morgan J., Lifson J., Mansfield K.G., Lang S., Johnson R.P., Skowronski J., and Desrosiers R. Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J. Virol. 78 23 (2004) 13335-13344
47. Wei B.L., Arora V.K., Foster J.L., Sodora D.L., and Garcia J.V. In vivo analysis of Nef function. Curr. HIV Res. 1 1 (2003) 41-50
48. Williams M., Roeth J.F., Kasper M.R., Fleis R.I., Przybycin C.G., and Collins K.L. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76 23 (2002) 12173-12184
49. Williams M., Roeth J.F., Kasper M.R., Filzen T.M., and Collins K.L. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J. Virol. 79 1 (2005) 632-636
50. Wiskerchen M., and Cheng-Mayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 224 1 (1996) 292-301